As adiponectin and leptin exert antagonistic effects on liver fibrogenesis and inflammation, the ratio of adiponectin to leptin may be a better marker for distinguishing NASH from NAFLD. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.